Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation

Prostaglandins
B J WhittleJ R Vane

Abstract

Carbacyclin is a chemically stable analogue of prostacyclin. As an inhibitor of platelet aggregation induced by ADP or collagen in vitro, carbacyclin is 0.03 times as active as prostacyclin in human, dog or rabbit plasma. Carbacyclin, like prostacyclin, reduces systemic arterial blood pressure (BP) in dogs, rabbits and rats and is not inactivated during passage through the pulmonary circulation. Further actions were investigated using a new ex vivo technique which allows rapid preparation of platelet-rich plasma and determination of platelet aggregation. In the dog, intravenous infusion of carbacyclin or prostacyclin inhibits platelet aggregation ex vivo with minimal effects on BP or heart rate. In the anaesthetised or conscious rabbit, carbacyclin and prostacyclin produces similar cardiovascular changes in doses producing an equivalent degree of platelet inhibition. In both rabbit and dog, carbacyclin is 0.1 times as active as prostacyclin in inhibiting ex vivo platelet aggregation. Platelet inhibition is maintained throughout the period of infusion of either compound (up to 3 h) yet is no longer apparent 10 min after terminating the infusion. Carbacyclin is thus a chemically-stable but metabolically-unstable analogue with a b...Continue Reading

Citations

Jun 1, 1981·Naunyn-Schmiedeberg's Archives of Pharmacology·K SchrörR Ohlendorf
Jul 1, 1985·British Journal of Plastic Surgery·D J CrabbB M O'Brien
Aug 3, 1984·European Journal of Pharmacology·D N HarrisT E Steinbacher
Dec 16, 1986·European Journal of Pharmacology·M HatmiB B Vargaftig
Jan 1, 1985·International Journal of Immunopharmacology·A E KingstonJ Ivanyi
Mar 1, 1983·Prostaglandins, Leukotrienes, and Medicine·B A SchölkensW Jung
Oct 1, 1984·Prostaglandins, Leukotrienes, and Medicine·M BergamaschiV Mandelli
Jan 1, 1996·Pharmacology & Therapeutics·R A Armstrong
Aug 1, 1986·Proceedings of the National Academy of Sciences of the United States of America·B J WhittleS Moncada
Aug 1, 1996·British Journal of Pharmacology·A J de Brum-FernandesC Patry
Mar 17, 2007·American Journal of Respiratory Cell and Molecular Biology·Koichiro KamioStephen I Rennard
Mar 21, 1998·Proceedings of the National Academy of Sciences of the United States of America·S Tertyshnikova, A Fein
Jan 30, 2007·Prostaglandins & Other Lipid Mediators·E M ZardiA Afeltra
Nov 5, 2003·Journal of Cellular and Molecular Medicine·O C Trifan, T Hla
May 5, 2007·The Journal of Physiology·Vladislav SnitsarevFrançois M Abboud
Feb 3, 2005·International Immunopharmacology·Enrico Maria ZardiAntonella Afeltra
Nov 1, 1987·Pharmacological Research Communications·D Oliva, S Nicosia
Jun 15, 2004·European Journal of Pharmacology·Vincent GiguèreJean-Luc Parent
Jul 21, 1988·Biochimica Et Biophysica Acta·A L TsaiK K Wu
Jul 13, 2016·Journal of Neuroinflammation·Ramy Habashy MaltyMichael R Vasko
Nov 10, 2004·Medical Hypotheses·Enrico Maria ZardiAntonella Afeltra
Dec 1, 1986·British Journal of Pharmacology·T AkibaN Toda

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.